Instituto Nacional de Cancer, Brazil Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3

Organization Overview

First Clinical Trial
2008
NCT01804205
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Department of Anesthesiology, Hospital do Câncer II, Instituto Nacional do Câncer | Susanne Crocamo

Active Ingredients

Drugs in Phase 3 Trials (1)

lidocaine (xylocaine) (1 trial)

Drugs in Phase 2 Trials (1)

zoledronic acid (zometa) (1 trial)

Drugs in Phase 1 Trials (1)

magnesium sulfate (Tis-U-Sol) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Breast Diseases (Phase 2)

Breast Neoplasms (Phase 2)

Head and Neck Neoplasms (Phase 1)

Neoplasms (Phase 2)

Neoplasms by Site (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 3